ZoBio has launched a comprehensive DNA-Encoded Library (DEL) discovery service to aid in the identification of drug targets that are difficult or novel. This integrated platform combines multiple techniques, including protein production, biophysical assays, and structural characterization, to provide high-confidence starting points for drug development, addressing challenges faced by traditional screening methods.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
17
Ali NematiWritten by Ali
